Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1719595

	registered interest
	date	21/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bladder Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of people that have been (a) diagnosed with and (b) treated for bladder cancer in the last 12 months.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	27369
	answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>Whilst the Department will not make a specific estimate, the following link shows the number of diagnoses of bladder cancer in England for 2019 and 2020, the most recent years for which NHS Digital holds publicly available data:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2020/cancer-diagnoses-in-2020" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2020/cancer-diagnoses-in-2020</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 11:30:38 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4131 label Biography information for Jim Shannon

1719200

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what flexibility (a) NICE and (b) NHS England have to approve for use drugs that (i) are used in combination with other drugs, (ii) are used for various (A) conditions and (B) lines of treatment and (iii) provide significant benefits for some but not all patients; and what tools those organisations use to ensure the effectiveness of such appraisals.
	tabling member constituency	Birmingham, Yardley
	tabling member printed	Jess Phillips
	uin	27051
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines, and significant licence extensions for existing medicines, should be routinely funded by the NHS. The NICE is able to recommend most new medicines for use by the NHS, including as a result of commercial agreements negotiated between NHS England and the company, in line with the commercial framework for new medicines.</p><p>The NICE develops its guidance in line with its published health technology evaluations manual, which sets out the circumstances in which its Appraisal Committees are able to apply flexibility in the evaluation of specific treatments. The NICE is, for example, able to apply a modifier in the evaluation of medicines for severe diseases that means that its committees are able to recommend medicines at a higher cost-effectiveness threshold than for less severe diseases. The NICE appraises combination therapies using the same methods that it uses for appraising single drug therapies.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 16:08:56 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4370 label Biography information for Jess Phillips

1719241

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Redundancy Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether any ministerial redundancy payments have been repaid to her Department since 2019.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	27086
	answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 11:46:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4418 label Biography information for Justin Madders

1719284

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatic Enzyme Replacement Therapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help ensure the adequacy of access to (a) Creon and (b) other drugs that contain pancreatic enzymes for patients after pancreatic surgery.
	tabling member constituency	Broxbourne
	tabling member printed	Sir Charles Walker
	uin	26982
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>We are aware of supply issues with three pancreatic enzyme replacement therapies: Creon 10,000 gastro-resistant capsules; Creon 25,000 gastro-resistant capsules; and Nutrizym 22 gastro-resistant capsules. We understand that these are due to limited availability of active pharmaceutical ingredients, and manufacturing constraints in producing the volumes required to meet demand. The Department has issued guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products to ask that they expedite deliveries and increase production forecasts, and to confirm that they are taking action to address the root causes of the issues, to ensure continuity of supply. We are also working with specialist importers to source unlicensed imports from abroad.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 15:24:29 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1493 label Biography information for Sir Charles Walker

1719292

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prince's Trust: Contracts
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Minister without Portfolio's article of 12 May 2024 in The Sunday Telegraph, when her Department is expected to terminate its contract with the Prince's Trust, order reference C191156; and whether a notice period is required under the provisions of clause 10.2.2 of that contract.
	tabling member constituency	Islington South and Finsbury
	tabling member printed	Emily Thornberry
	uin	26990
	answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Dissolution.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 14:03:28 answering member 4044 label Biography information for Andrew Stephenson previous answer version 36822 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1536 label Biography information for Emily Thornberry

1719342

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	South Asia Bio Bank: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will have discussions with (a) the National Institute for Health Research and (b) other NHS funding streams on the potential merits of increasing the level of funding made available to the South Asian Biobank to help monitor (i) disease diagnoses and (ii) health outcomes from that project among people from South Asian backgrounds.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	27023
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The South Asian Biobank, originally funded by the Wellcome Trust, is an international research study designed to prevent the high risk of cardiovascular disease, diabetes, and cancer among South Asian people. The National Institute for Health and Care Research (NIHR) funds research via a range of programmes, with eligibility criteria to support applicants to decide where to apply. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. The NIHR has provided funding for research projects associated with the South Asian Biobank through open competition, and welcomes any future applications. In addition, the NIHR provides funding to NIHR research infrastructure through open competition. The NIHR Imperial Biomedical Research Centre and the Clinical Research Network have provided support for the South Asian Biobank.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 27025 question first answered 23/05/2024 07:42:45 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4076 label Biography information for Valerie Vaz

1719343

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	UK Biobank: Ethnic Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions she has had with (a) UK Biobank and (b) UK Biobank funders on the adequacy of the proportion of UK Biobank participants from BAME backgrounds.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	27024
	answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>The scientific and ethical impacts of cohort diversity on the generalisability of research findings is part of ongoing conversations on health data, including with UK Biobank. As a funder, the Government routinely engages in discussions about diversity with UK Biobank through the Medical Research Council and National Institute for Health and Care Research. The Department is committed to increasing participation of ethnic minority groups in health and social care research, and is working in partnership with diverse communities to ensure they have a stronger voice in shaping priorities for research, the design and delivery of research, inclusive recruitment into studies, and the mobilisation of evidence into practice.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 13:29:24 answering member 4044 label Biography information for Andrew Stephenson previous answer version 36821 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4076 label Biography information for Valerie Vaz

1719345

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	South Asia Bio Bank: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of increasing the level of funding allocated to the South Asian Biobank.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	27025
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The South Asian Biobank, originally funded by the Wellcome Trust, is an international research study designed to prevent the high risk of cardiovascular disease, diabetes, and cancer among South Asian people. The National Institute for Health and Care Research (NIHR) funds research via a range of programmes, with eligibility criteria to support applicants to decide where to apply. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. The NIHR has provided funding for research projects associated with the South Asian Biobank through open competition, and welcomes any future applications. In addition, the NIHR provides funding to NIHR research infrastructure through open competition. The NIHR Imperial Biomedical Research Centre and the Clinical Research Network have provided support for the South Asian Biobank.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 27023 question first answered 23/05/2024 07:42:45 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4076 label Biography information for Valerie Vaz

1719369

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services and Social Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of children that have lost their place on waiting lists for health and care services as a result of relocating out of area due to housing pressures, in the latest period for which data is available.
	tabling member constituency	Salford and Eccles
	tabling member printed	Rebecca Long Bailey
	uin	27056
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>It is important that the correct start date is captured for patients who transfer from a referral to treatment (RTT) pathway between providers. For patients that move between different areas of England and transfer to a new provider, including children who may relocate out of an area due to housing pressures, there is an established Inter Provider Transfer process which ensures that the patient is transferred with the same RTT clock start date, so that the new provider considers the amount of time the patient has already waited. This is detailed in Section 11.3 of NHS England’s Recording and reporting RTT waiting times for consultant-led elective care guidance, which is available at the following link:</p><p><a href="https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2024/02/Recording-and-reporting-referral-to-treatment-RTT-waiting-times-for-consultant-led-elective-care-v4-1.pdf" target="_blank">https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2024/02/Recording-and-reporting-referral-to-treatment-RTT-waiting-times-for-consultant-led-elective-care-v4-1.pdf</a></p><p>Data on the number of children that have lost their place on waiting lists for health and care services as a result of relocating out of area due to housing pressures is not collected, therefore no estimate has been made.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 16:39:26 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4396 label Biography information for Rebecca Long Bailey

1719420

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Attention Deficit Hyperactivity Disorder: Weaver Vale
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the adequacy of the availability of attention deficit hyperactivity disorder medication in Weaver Vale constituency.
	tabling member constituency	Weaver Vale
	tabling member printed	Mike Amesbury
	uin	27158
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Department has been working hard with industry to help resolve supply issues with some attention deficit hyperactivity disorder (ADHD) medicines, which are affecting the United Kingdom and other countries around the world. This has involved asking that suppliers expedite deliveries to boost supplies of these important medicines, and address regulatory issues to ensure continuity of supply. As a result of our ongoing activity and intensive work, some issues have been resolved. Many strengths of lisdexamphetamine and all strengths of atomoxetine capsules and guanfacine are now available, although medicine supply issues remain for some strengths of lisdexamphetamine and methylphenidate. We continue to escalate these issues with manufacturers to ensure that they are taking responsibility for resolving them as quickly as possible, and to drive and monitor progress.</p><p>We monitor and manage medicine supply at a national level so that stocks remain available to meet regional and local demand. The Department does not hold information on stockholdings at a local level.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 16:47:55 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4667 label Biography information for Mike Amesbury

1719437

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that Liothyronine is acquired by the NHS at the best possible price.
	tabling member constituency	Portsmouth South
	tabling member printed	Stephen Morgan
	uin	27175
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Liothyronine is marketed as a generic medicine. For generic medicines, we rely on competition to keep prices down. This works well for the most part, as evidence shows we have amongst the lowest prices in Europe for generic medicines. The system also means we have a relatively resilient supply, as flexibility on pricing allows manufacturers to increase prices where supply on a particular drug is reduced or demand increases, supporting continuity of supply for patients in the United Kingdom.</p><p>Between 2009 and 2017, there was only one supplier of liothyronine, and they were charging a price considered to be excessive and unfair by the Competition and Markets Authority (CMA). Following an investigation which concluded in July 2021, the CMA decided to issue fines totalling £101.4 million against the three undertakings which controlled the supply during this time.</p><p>That decision is currently under appeal before the Court of Appeal, having previously been upheld by the Competition Appeal Tribunal in August 2023. Since 2016, several marketing authorisations have been granted to other suppliers for liothyronine, and its price to the National Health Service has been decreasing as a result of direct competition in the market. The Department has no price comparison information on liothyronine.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 27176 question first answered 23/05/2024 16:45:16 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4653 label Biography information for Stephen Morgan

1719438

	registered interest
	date	20/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department has made a comparative estimate of the cost of Liothyronine in (a) the UK and (b) other countries.
	tabling member constituency	Portsmouth South
	tabling member printed	Stephen Morgan
	uin	27176
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Liothyronine is marketed as a generic medicine. For generic medicines, we rely on competition to keep prices down. This works well for the most part, as evidence shows we have amongst the lowest prices in Europe for generic medicines. The system also means we have a relatively resilient supply, as flexibility on pricing allows manufacturers to increase prices where supply on a particular drug is reduced or demand increases, supporting continuity of supply for patients in the United Kingdom.</p><p>Between 2009 and 2017, there was only one supplier of liothyronine, and they were charging a price considered to be excessive and unfair by the Competition and Markets Authority (CMA). Following an investigation which concluded in July 2021, the CMA decided to issue fines totalling £101.4 million against the three undertakings which controlled the supply during this time.</p><p>That decision is currently under appeal before the Court of Appeal, having previously been upheld by the Competition Appeal Tribunal in August 2023. Since 2016, several marketing authorisations have been granted to other suppliers for liothyronine, and its price to the National Health Service has been decreasing as a result of direct competition in the market. The Department has no price comparison information on liothyronine.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 27175 question first answered 23/05/2024 16:45:16 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4653 label Biography information for Stephen Morgan

1719042

	registered interest
	date	17/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Haemochromatosis: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of diagnosis rates for genetic haemochromatosis.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	26852
	answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>While data is not held centrally on diagnosis rates for genetic haemochromatosis, genomic testing for haemochromatosis is available through the NHS Genomic Medicines Service (GMS) for patients in England who show an unexplained iron overload, suggestive of genetic haemochromatosis. Any clinician who suspects haemochromatosis can order this testing via local genomic laboratory hubs.</p><p>Seven NHS GMS Alliances play an important role in supporting the strategic systematic embedding of genomic medicine in end-to-end clinical pathways and clinical specialities. They help to achieve equitable access to standardised end-to-end pathways of care, inclusive of genomic testing, clinical genetics, and genomic counselling services. The alliances also raise awareness among clinicians and the public of the genomic testing available through the National Health Service and drive this embedding across all providers within their geography, from primary and community care to secondary and tertiary care.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/05/2024 19:44:14 answering member 4044 label Biography information for Andrew Stephenson previous answer version 35987 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1409 label Biography information for Mr Gregory Campbell

1719049

	registered interest
	date	17/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Neurofibromatosis: Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of automatically notifying women with neurofibromatosis type 1 before their 40th birthday that they are eligible to attend breast cancer screening from the age of 40 years.
	tabling member constituency	Blaydon
	tabling member printed	Liz Twist
	uin	26906
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Currently women with neurofibromatosis type 1 (NF1) who are considered at moderate or high risk of breast cancer, can be referred through clinical professionals such as specialists in genetics or oncology for annual breast screening which is managed at a local level.</p><p>An assessment has not made of the potential merits of automatically notifying women with NF1 before they are 40 years old that they are eligible to attend breast cancer screening from the age of 40 years.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 08:07:57 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4618 label Biography information for Liz Twist

1719051

	registered interest
	date	17/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Neurofibromatosis: Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she has taken with NHS England to help raise awareness by (a) patients and (b) GPs of the increased risk of breast cancer in people with neurofibromatosis type 1.
	tabling member constituency	Blaydon
	tabling member printed	Liz Twist
	uin	26907
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Department works with NHS England to raise awareness of cancers, including for people with increased risk of cancer. In January 2024, NHS England relaunched the Help Us Help You cancer awareness campaign, designed to increase earlier diagnosis by encouraging people to come forward with suspected signs of cancers.</p><p>For individuals with neurofibromatosis type 1 (NF1), who are at increased risk of breast cancer, the National Health Service in England recommends breast screening from the age of 40 years old. It is important that awareness of this is widespread among patients and general practices (GPs). Treatment for NF1 involves regular monitoring, and if a patient develops complex problems, their GP can usually refer them to one of two specialist NHS centres, so that a treatment plan can be drawn up. These centres are at Guy’s and St Thomas’ in London, and at Manchester University Hospital.</p><p>We expect clinicians to keep themselves appraised of developments within conditions, and to refer to the National Institute for Clinical Excellence guidance as part of their clinical decision-making process.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 08:05:03 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4618 label Biography information for Liz Twist

1719053

	registered interest
	date	17/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Methylphenidate
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with Janssen on the adequacy of supply of the ADHD medication Concerta XL.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	26903
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Department has been working hard with industry to help resolve supply issues with some attention deficit hyperactivity disorder (ADHD) medicines, including Concerta XL tablets, which are affecting the United Kingdom and other countries around the world. This has involved asking that suppliers expedite deliveries to boost supplies of these important medicines, and addressing regulatory issues to ensure continuity of supply. As a result of our ongoing activity and intensive work, some issues have been resolved. We expect the disruptions to the supply of Concerta XL tablets to be resolved in May 2024.</p><p>The Department held a roundtable with all suppliers of methylphenidate prolonged-release tablet suppliers, including Janssen, in April 2024, to discuss the challenges they are facing, what they are doing, and what needs to be done to address these issues.</p><p>We have worked closely with specialist clinicians during this time to develop management advice for the National Health Service. The guidance includes advice for ADHD service providers and specialists to offer rapid response to primary care teams seeking urgent advice for the management of patients. This includes those known to be at a higher risk of adverse impact because of these shortages.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26904 question first answered 23/05/2024 15:25:17 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4523 label Biography information for Catherine West

1719054

	registered interest
	date	17/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Methylphenidate
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure patients have access to Concerta XL.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	26904
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The Department has been working hard with industry to help resolve supply issues with some attention deficit hyperactivity disorder (ADHD) medicines, including Concerta XL tablets, which are affecting the United Kingdom and other countries around the world. This has involved asking that suppliers expedite deliveries to boost supplies of these important medicines, and addressing regulatory issues to ensure continuity of supply. As a result of our ongoing activity and intensive work, some issues have been resolved. We expect the disruptions to the supply of Concerta XL tablets to be resolved in May 2024.</p><p>The Department held a roundtable with all suppliers of methylphenidate prolonged-release tablet suppliers, including Janssen, in April 2024, to discuss the challenges they are facing, what they are doing, and what needs to be done to address these issues.</p><p>We have worked closely with specialist clinicians during this time to develop management advice for the National Health Service. The guidance includes advice for ADHD service providers and specialists to offer rapid response to primary care teams seeking urgent advice for the management of patients. This includes those known to be at a higher risk of adverse impact because of these shortages.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26903 question first answered 23/05/2024 15:25:17 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4523 label Biography information for Catherine West

1719056

	registered interest
	date	17/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dentistry: Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 April 2024 to Question 23057 on Dentistry: Mental Health Services, what her Department's expected timetable is for publishing the findings of its review into its mental health and wellbeing offer.
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	uin	26923
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>NHS England is in the process of reviewing its mental health and wellbeing offer for National Health Service staff, and has committed to completing this review in 2024/25.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 08:01:42 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4811 label Biography information for Navendu Mishra

1718758

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatic Cancer: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve (a) research into treatments for and (b) (i) emotional and (ii) financial support for people living with pancreatic cancer.
	tabling member constituency	Putney
	tabling member printed	Fleur Anderson
	uin	26771
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Research is crucial in tackling cancer, which is why the Department invests £1.3 billion per year in health research, through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23, and the NIHR spends more on cancer than any other disease group. <br> <br> The NIHR funded nine research projects on pancreatic cancer since 2018/19, with a committed funding value of £4.3 million. The NIHR continues to welcome funding applications for research into any aspect of human health, including pancreatic cancer. Applications are subject to peer review and judged in open competition. <br> <br> The NIHR also supports delivery of research into pancreatic cancer in the health and care system, funded by research funding partners in the charity and public sectors. Since 2018/19 the NIHR supported 73 clinical research studies through the Clinical Research Network. <br> <br> Additionally, NIHR Biomedical Research Centres (BRC) and NIHR Clinical Research Facilities spent a further £6.5 million between 2018/19 and 2022/23, supporting an annual portfolio of approximately 85 early clinical studies into pancreatic cancer. NIHR BRCs are collaborations between world-leading universities and National Health Service organisations, that bring together academics and clinicians to translate discoveries from basic or discovery science into clinical research. <br> <br> For emotional and financial support, patient feedback is monitored through the National Cancer Patient Experience Survey, with the latest results showing an overall experience of 8.88 out of 10. In areas such as support for health and wellbeing, and information on financial help, results were positive but showed room for improvement. NHS England continues to support trusts to take action to improve cancer patient support.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 08:21:01 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4788 label Biography information for Fleur Anderson

1718766

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of offering breast cancer screening to women going through early menopause.
	tabling member constituency	Putney
	tabling member printed	Fleur Anderson
	uin	26776
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The UK National Screening Committee (UK NSC) currently recommends that all women aged 50 to 71 years old are invited for a breast screening every three years. The AgeX trial is looking at the impact of increasing or decreasing the screening age for breast screening, and the UK NSC will review its findings when they are available.</p><p>The UK NSC can be alerted to any new published peer reviewed evidence which may suggest the case for a new screening programme, or changes to an existing one. Proposals can be submitted via the UK NSC’s annual call in July 2024, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/uk-nsc-annual-call-submitting-a-screening-proposal/uk-nsc-annual-call-how-to-submit-a-proposal#:~:text=To%20submit%20a%20proposal%20for,your%20name" target="_blank">https://www.gov.uk/government/publications/uk-nsc-annual-call-submitting-a-screening-proposal/uk-nsc-annual-call-how-to-submit-a-proposal#:~:text=To%20submit%20a%20proposal%20for,your%20name</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/05/2024 16:51:28 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4788 label Biography information for Fleur Anderson

1718804

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department (a) has and (b) plans to provide funding for new treatments for ME or chronic fatigue syndrome.
	tabling member constituency	Leeds North East
	tabling member printed	Fabian Hamilton
	uin	26662
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The Department, through the National Institute for Health and Care Research (NIHR), provides funding for research projects which aim to understand the underlying causes of myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), and find new treatments for the condition. As part of this, the NIHR and the Medical Research Council have funded the world’s largest genome-wide association study of ME/CFS. This £3.2 million study, termed DecodeME, will analyse samples from 25,000 people with ME/CFS to search for genetic differences that may indicate underlying causes, or an increased risk of developing the condition. By helping us to understand ME/CFS better, this research has the potential to lead to new treatments for the condition.</p><p>Integrated care boards (ICBs) are responsible for commissioning specialist ME/CFS services that meet the needs of their population, subject to local prioritisation and funding. The process of commissioning services should take into account best practice guidance, such as the National Institute for Health and Care Excellence’s guidance on ME/CFS diagnosis and management, published in October 2021. In addition, in October 2023, the British Association of Clinicians in ME/CFS published the ME/CFS National Services Survey. This report provides insight into the services being delivered for adults, children, and young people with ME/CFS.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26663 question first answered 21/05/2024 08:08:03 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	415 label Biography information for Fabian Hamilton

1718805

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the adequacy of NHS provision of specialist ME or chronic fatigue syndrome services; and if she will take steps to increase the number of clinicians who specialise in ME or chronic fatigue syndrome.
	tabling member constituency	Leeds North East
	tabling member printed	Fabian Hamilton
	uin	26663
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The Department, through the National Institute for Health and Care Research (NIHR), provides funding for research projects which aim to understand the underlying causes of myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), and find new treatments for the condition. As part of this, the NIHR and the Medical Research Council have funded the world’s largest genome-wide association study of ME/CFS. This £3.2 million study, termed DecodeME, will analyse samples from 25,000 people with ME/CFS to search for genetic differences that may indicate underlying causes, or an increased risk of developing the condition. By helping us to understand ME/CFS better, this research has the potential to lead to new treatments for the condition.</p><p>Integrated care boards (ICBs) are responsible for commissioning specialist ME/CFS services that meet the needs of their population, subject to local prioritisation and funding. The process of commissioning services should take into account best practice guidance, such as the National Institute for Health and Care Excellence’s guidance on ME/CFS diagnosis and management, published in October 2021. In addition, in October 2023, the British Association of Clinicians in ME/CFS published the ME/CFS National Services Survey. This report provides insight into the services being delivered for adults, children, and young people with ME/CFS.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26662 question first answered 21/05/2024 08:08:03 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	415 label Biography information for Fabian Hamilton

1718810

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hydrotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what data her Department holds on the number of hydrotherapy centres (a) due to be closed and (b) under consideration for closure by NHS (i) trusts and (ii) integrated care boards.
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	uin	26785
	answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>Health services are commissioned locally by integrated care boards, which are best placed to make decisions regarding the provision of health services, including hydrotherapy, to their local population, subject to local prioritisation and funding.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/05/2024 09:18:22 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4811 label Biography information for Navendu Mishra

1718862

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Payments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many responses were received to her Department's consultation entitled The disclosure of industry payments to the healthcare sector, which closed on 16 October 2023; and what her planned timetable is to respond to that consultation.
	tabling member constituency	Shipley
	tabling member printed	Sir Philip Davies
	uin	26667
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The Department launched a United Kingdom-wide public consultation on 4 September 2023 on the disclosure of industry payments to the healthcare sector. The consultation sought views on the possible introduction of regulations through new secondary legislation, as well as views on alternative options to regulations. There were 603 responses to the consultation. The Department is analysing the responses, and the Government’s response will be published in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/05/2024 16:47:43 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1565 label Biography information for Sir Philip Davies

1718901

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Fractures: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many patients were referred to the Fracture Liaison Service with fragility fractures in each of the last five years; and what proportion of those patients were women over the age of 50.
	tabling member constituency	Swansea East
	tabling member printed	Carolyn Harris
	uin	26702
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>While NHS England does not hold this information centrally, data in relation to the Fracture Liaison Services (FLS) can be found in the FLS-Database Annual reports. The 2024 report, which includes data in relation to gender, is available at the following link:</p><p><a href="https://www.hqip.org.uk/wp-content/uploads/2024/02/Ref-419-FLS-DB-2024-annual-report-1.pdf" target="_blank">https://www.hqip.org.uk/wp-content/uploads/2024/02/Ref-419-FLS-DB-2024-annual-report-1.pdf</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26703 question first answered 23/05/2024 08:17:07 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4480 label Biography information for Carolyn Harris

1718902

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Fractures: Women
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of the women over the age of 50 that were referred to the Fracture Liaison Service with fragility fractures were (a) taking hormone replacement therapy (HRT) prior to their first fragility fracture and (b) prescribed HRT as part of their treatment after their first fragility fracture in each of the last five years.
	tabling member constituency	Swansea East
	tabling member printed	Carolyn Harris
	uin	26703
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>While NHS England does not hold this information centrally, data in relation to the Fracture Liaison Services (FLS) can be found in the FLS-Database Annual reports. The 2024 report, which includes data in relation to gender, is available at the following link:</p><p><a href="https://www.hqip.org.uk/wp-content/uploads/2024/02/Ref-419-FLS-DB-2024-annual-report-1.pdf" target="_blank">https://www.hqip.org.uk/wp-content/uploads/2024/02/Ref-419-FLS-DB-2024-annual-report-1.pdf</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26702 question first answered 23/05/2024 08:17:07 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4480 label Biography information for Carolyn Harris

1718910

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tomography
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of (a) CT and (b) MRI scanners have been in operation for longer than 10 years.
	tabling member constituency	Bristol South
	tabling member printed	Karin Smyth
	uin	26699
	answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Dissolution.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 14:03:34 answering member 4044 label Biography information for Andrew Stephenson previous answer version 35675 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4444 label Biography information for Karin Smyth

1718911

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Trusts: ICT
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many IT failures there have been at NHS trusts in each of the last five years.
	tabling member constituency	Bristol South
	tabling member printed	Karin Smyth
	uin	26700
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The information requested is not held centrally.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26701 question first answered 21/05/2024 16:28:55 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4444 label Biography information for Karin Smyth

1718912

	registered interest
	date	16/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Trusts: ICT
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many IT failures there have been at NHS trusts that affected clinical service delivery in each of the last five years.
	tabling member constituency	Bristol South
	tabling member printed	Karin Smyth
	uin	26701
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The information requested is not held centrally.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26700 question first answered 21/05/2024 16:28:55 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4444 label Biography information for Karin Smyth

1718277

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatic Enzyme Replacement Therapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that patients taking pancreatic enzymes continue to receive them.
	tabling member constituency	Walthamstow
	tabling member printed	Stella Creasy
	uin	26452
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>We are aware of supply issues with three pancreatic enzyme replacement therapies: Creon 10000 gastro-resistant capsules; Creon 25000 gastro-resistant capsules; and Nutrizym 22 gastro-resistant capsules. We understand that these are due to limited availability of active pharmaceutical ingredients, and manufacturing constraints in producing the volumes required to meet demand. The Department has issued guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products, to ask that they expedite deliveries and increase production forecasts, and to confirm that they are taking action to address the root causes of the issues, to ensure continuity of supply. We are also working with specialist importers to source unlicensed imports from abroad.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 16:55:17 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4088 label Biography information for Stella Creasy

1718305

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Disability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps their Department is taking to support the Disability Confident scheme; how many officials in their Department work directly on supporting that scheme; what assessment they have made of the effectiveness of that work in supporting the (a) recruitment and (b) retention of disabled people in their Department; and what further steps they are taking to support their Department’s recruitment and retention of disabled people.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	26436
	answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>The Department proudly supports the Disability Confident Scheme, and has renewed its status as a Disability Confident employer. No single official works directly on the scheme, and in line with Civil Service guidance, we have moved away from standalone roles and teams to embed equality, diversity, and inclusion activities within existing human resource portfolios and roles. Activity to support the recruitment and retention of colleagues with a disability is undertaken across our recruitment, talent, and employee experience teams.</p><p>In the last calendar year, 11.3% of successful applicants applied under the Disability Confident Scheme. This is a slight increase from last year, at 10.9%. We additionally review our disability representation rates on a regular basis to monitor the impact of our recruitment practices and policy changes. We also have dedicated staff networks to support our disabled employees and celebrate achievements. Turnover of permanent employees who have declared they have a disability is currently approximately 6%, which is significantly lower than the average permanent staff turnover of colleagues who do not have a declared disability.</p><p>In 2023, we launched a new Workplace Adjustments policy, process, and passport. The new process is designed to ensure everyone in the Department can access the support they need as easily and quickly as possible via a person-centred approach that identifies and seeks to remove workplace barriers.</p><p>We also delivered several talent schemes that can assist in supporting the retention and development of disabled colleagues. This includes Beyond Boundaries, a 12-month programme for the Senior Executive Officer grade and below, to support candidates in reaching their full potential. As part of the programme, to support disability positive action, last year we ringfenced six job places out of 30, based on the proportionality of our disabled workforce, the People Survey, and recruitment data. We expect to take similar action this year.</p><p>In addition, the Future Leaders Scheme (FLS) is a 12-month accelerated development scheme for Grade 6 or 7 colleagues, who have the potential to progress to the Civil Service’s most senior and critical leadership roles. There is an option for those candidates who declare a disability or long-term health condition, or both, to enrol on the Disability Empowers Leadership Talent Association (DELTA) integrated scheme. In 2022, we had four candidates participate in DELTA out of the 21 successful FLS candidates, and two out of 26 in 2021, as per the data from the Cabinet Office. It should be noted that due to the sensitive nature of the programmes, not all participants are comfortable in being open about participation in DELTA, especially those with disabilities who have yet to disclose this to their colleagues or managers.</p><p>Finally, the Department’s mutual mentoring programme encourages underrepresented groups, including colleagues with disabilities, to mentor senior civil service colleagues to help increase the engagement and retention of underrepresented staff, and increase cultural intelligence in senior leaders.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 13:30:25 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4048 label Biography information for Caroline Nokes

1718317

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Junior Doctors: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an estimate of the average earnings received by junior doctors in addition to basic pay in each of the last five years.
	tabling member constituency	Hendon
	tabling member printed	Dr Matthew Offord
	uin	26417
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The following table shows the estimated annual basic pay, total earnings, and non-basic pay per person for doctors at Junior Doctor level, each year from 2018/19 to 2022/23, the latest year for which data is available:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>Mean annual earnings per person</p></td><td><p>£52,062</p></td><td><p>£52,616</p></td><td><p>£54,569</p></td><td><p>£55,422</p></td><td><p>£56,661</p></td></tr><tr><td><p>Mean annual basic pay per person</p></td><td><p>£37,237</p></td><td><p>£38,128</p></td><td><p>£39,255</p></td><td><p>£40,669</p></td><td><p>£41,876</p></td></tr><tr><td><p>Mean annual non-basic pay per person</p></td><td><p>£14,825</p></td><td><p>£14,489</p></td><td><p>£15,314</p></td><td><p>£14,753</p></td><td><p>£14,785</p></td></tr></tbody></table><p>Source: estimates are based on published figures from the NHS Staff Earnings Estimates and reweighted using headcount data from the NHS Workforce Statistics, both of which are available respectively at the following links:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-staff-earnings-estimates/december-2023" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-staff-earnings-estimates/december-2023</a></p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 16:11:31 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4006 label Biography information for Dr Matthew Offord

1718325

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Equality
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the cost to the public purse was of staff diversity networks in her Department in each of the last five years.
	tabling member constituency	South Holland and The Deepings
	tabling member printed	Sir John Hayes
	uin	26342
	answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Dissolution.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/05/2024 13:59:59 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	350 label Biography information for Sir John Hayes

1718454

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Brain Cancer: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the press notice entitled Major agreement to deliver new cancer vaccine trials, published on 5 July 2023, whether brain cancer patients will be given access to the treatments and therapies made available through that programme.
	tabling member constituency	St Albans
	tabling member printed	Daisy Cooper
	uin	26614
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The Government’s partnership with BioNTech aims to provide up to 10,000 United Kingdom patients with personalised immunotherapies by 2030. As well as cancer vaccines, BioNTech has several other classes of cancer therapy under development, such as engineered cell therapies and antibodies. We are not able to comment at this stage on the exact pipeline of clinical trials that BioNTech will go on to launch in the UK, over the coming years.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/05/2024 16:55:31 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4769 label Biography information for Daisy Cooper

1718464

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coeliac Disease: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, who is responsible for diagnosis of coeliac disease within NHS England; and what steps her Department takes to (a) monitor the adequacy of diagnostic services for coeliac disease and (b) ensure accountability of that role holder.
	tabling member constituency	Manchester, Withington
	tabling member printed	Jeff Smith
	uin	26511
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>Diagnostic services, including tests for coeliac disease, are provided in a range of settings, including community diagnostic centres (CDCs). We are expanding diagnostic capacity through the delivery of the CDC programme. NHS England assesses the delivery of diagnostic services, including by analysing regular management information for activity in CDCs as well as a national data collection for gastroscopy.</p><p>NHS England has also invested in senior clinical leadership in gastroenterology, which includes coeliac disease, as a priority workstream in the national Getting It Right First Time programme. However, it is the responsibility of integrated care boards (ICBs) to commission services to meet the needs of their local populace, including the diagnosis and ongoing management of coeliac disease.</p><p>The Government and NHS England are taking steps to support people waiting for appointments and surgery for long-term conditions, including those waiting for a coeliac disease diagnosis, by offering online support, increasing elective capacity, and encouraging personalised support.</p><p>NHS England launched the My Planned Care platform in February 2022, giving patients advice and support to manage their health, and avoid significant deterioration of symptoms whilst they wait for appointments. This online platform includes advice on physical and mental health. In addition, through the NHS Long Term Plan, the Government is providing record levels of investment and increasing the mental health workforce to expand and transform National Health Service mental health services in England, helping to reduce waiting times.</p><p>The National Institute for Health and Care Excellence promotes its guidance on coeliac disease, which includes information for the public via its website, newsletters, and other media.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26512 26513 question first answered 21/05/2024 16:52:21 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4456 label Biography information for Jeff Smith

1718465

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coeliac Disease: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate her Department has made of the average timescale for a diagnosis of coeliac disease from the point a person presents to their GP with symptoms; and what assessment she has made of the impact of the time taken for a diagnosis on patient mental and physical health.
	tabling member constituency	Manchester, Withington
	tabling member printed	Jeff Smith
	uin	26512
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>Diagnostic services, including tests for coeliac disease, are provided in a range of settings, including community diagnostic centres (CDCs). We are expanding diagnostic capacity through the delivery of the CDC programme. NHS England assesses the delivery of diagnostic services, including by analysing regular management information for activity in CDCs as well as a national data collection for gastroscopy.</p><p>NHS England has also invested in senior clinical leadership in gastroenterology, which includes coeliac disease, as a priority workstream in the national Getting It Right First Time programme. However, it is the responsibility of integrated care boards (ICBs) to commission services to meet the needs of their local populace, including the diagnosis and ongoing management of coeliac disease.</p><p>The Government and NHS England are taking steps to support people waiting for appointments and surgery for long-term conditions, including those waiting for a coeliac disease diagnosis, by offering online support, increasing elective capacity, and encouraging personalised support.</p><p>NHS England launched the My Planned Care platform in February 2022, giving patients advice and support to manage their health, and avoid significant deterioration of symptoms whilst they wait for appointments. This online platform includes advice on physical and mental health. In addition, through the NHS Long Term Plan, the Government is providing record levels of investment and increasing the mental health workforce to expand and transform National Health Service mental health services in England, helping to reduce waiting times.</p><p>The National Institute for Health and Care Excellence promotes its guidance on coeliac disease, which includes information for the public via its website, newsletters, and other media.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26511 26513 question first answered 21/05/2024 16:52:21 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4456 label Biography information for Jeff Smith

1718466

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coeliac Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help increase public awareness of coeliac disease.
	tabling member constituency	Manchester, Withington
	tabling member printed	Jeff Smith
	uin	26513
	answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>Diagnostic services, including tests for coeliac disease, are provided in a range of settings, including community diagnostic centres (CDCs). We are expanding diagnostic capacity through the delivery of the CDC programme. NHS England assesses the delivery of diagnostic services, including by analysing regular management information for activity in CDCs as well as a national data collection for gastroscopy.</p><p>NHS England has also invested in senior clinical leadership in gastroenterology, which includes coeliac disease, as a priority workstream in the national Getting It Right First Time programme. However, it is the responsibility of integrated care boards (ICBs) to commission services to meet the needs of their local populace, including the diagnosis and ongoing management of coeliac disease.</p><p>The Government and NHS England are taking steps to support people waiting for appointments and surgery for long-term conditions, including those waiting for a coeliac disease diagnosis, by offering online support, increasing elective capacity, and encouraging personalised support.</p><p>NHS England launched the My Planned Care platform in February 2022, giving patients advice and support to manage their health, and avoid significant deterioration of symptoms whilst they wait for appointments. This online platform includes advice on physical and mental health. In addition, through the NHS Long Term Plan, the Government is providing record levels of investment and increasing the mental health workforce to expand and transform National Health Service mental health services in England, helping to reduce waiting times.</p><p>The National Institute for Health and Care Excellence promotes its guidance on coeliac disease, which includes information for the public via its website, newsletters, and other media.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26511 26512 question first answered 21/05/2024 16:52:21 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4456 label Biography information for Jeff Smith

1718481

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Integrated Care Systems
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the overall year end deficit for integrated care systems was in the financial year 2023-24.
	tabling member constituency	Bristol South
	tabling member printed	Karin Smyth
	uin	26506
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The final year-end financial position for the integrated care boards, National Health Service trusts, and foundation trusts has not yet been finalised. All figures are due to be audited and will be reported in the accounts for all organisations, as well as in the Department’s 2023/24 Annual Report and Accounts, to be published later this year.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26507 26508 question first answered 20/05/2024 13:45:52 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4444 label Biography information for Karin Smyth

1718483

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Integrated Care Systems and NHS Trusts: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many NHS (a) integrated care systems and (b) trusts were in deficit at the end of the 2023-24 financial year; and if she will publish a breakdown of those figures by (i) acute, (ii) mental health, (iii) community health, (iv) ambulance services and (v) other types of trust.
	tabling member constituency	Bristol South
	tabling member printed	Karin Smyth
	uin	26507
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The final year-end financial position for the integrated care boards, National Health Service trusts, and foundation trusts has not yet been finalised. All figures are due to be audited and will be reported in the accounts for all organisations, as well as in the Department’s 2023/24 Annual Report and Accounts, to be published later this year.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26506 26508 question first answered 20/05/2024 13:45:52 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4444 label Biography information for Karin Smyth

1718484

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Integrated Care Systems: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much each NHS Integrated Care Systems owed to NHS England for historic deficits at the end of the 2023-24 financial year.
	tabling member constituency	Bristol South
	tabling member printed	Karin Smyth
	uin	26508
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The final year-end financial position for the integrated care boards, National Health Service trusts, and foundation trusts has not yet been finalised. All figures are due to be audited and will be reported in the accounts for all organisations, as well as in the Department’s 2023/24 Annual Report and Accounts, to be published later this year.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26506 26507 question first answered 20/05/2024 13:45:52 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4444 label Biography information for Karin Smyth

1718485

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Trusts: Buildings
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, in how many NHS trusts temporary buildings are in use.
	tabling member constituency	Bristol South
	tabling member printed	Karin Smyth
	uin	26509
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The National Health Service does not hold data on the number of temporary buildings in use.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 16:27:52 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4444 label Biography information for Karin Smyth

1718486

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Trusts: Infrastructure
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many infrastructure failures at NHS trusts have been recorded in each of the last five years; and how many such failures had an impact on clinical service delivery in each of those years.
	tabling member constituency	Bristol South
	tabling member printed	Karin Smyth
	uin	26510
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The National Health Service publishes the annual Estates Returns Information Collection, which includes detailed information on the NHS estate. Individual NHS Trusts are responsible for providing the data for the Estates Returns Information Collection and ensuring the accuracy of their returns. The information can be found at:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/estates-returns-information-collection" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/estates-returns-information-collection</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 15:49:41 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4444 label Biography information for Karin Smyth

1718491

	registered interest
	date	15/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Paramedical Staff: Sexual Offences
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking with the Secretary of State for Health and Social Care to help end sexual abuse of female paramedics in the workplace.
	tabling member constituency	Warrington North
	tabling member printed	Charlotte Nichols
	uin	26622
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The National Health Service takes reports of sexual abuse of its staff extremely seriously. NHS England welcomed the recommendations of the recent independent review of the ambulance sector culture, Culture Review of Ambulance Trusts, which highlights the need to target bullying and harassment, including sexual harassment, and enable freedom to speak up. The report is available at the following link:</p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2024/02/Culture-review-of-ambulance-trusts.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2024/02/Culture-review-of-ambulance-trusts.pdf</a></p><p>These recommendations are now being implemented, alongside actions related to the report by the Office of the Chief Allied Health Professions at NHS England and the Association of Ambulance Chief Executives (AACE), entitled Reducing Misogyny and Improving Sexual Safety in the Ambulance Service, which is available at the following link:</p><p><a href="https://aace.org.uk/reducing-misogyny-and-improving-sexual-safety-in-the-ambulance-service/" target="_blank">https://aace.org.uk/reducing-misogyny-and-improving-sexual-safety-in-the-ambulance-service/</a></p><p>To emphasise the zero-tolerance approach to sexual misconduct in the NHS, last September, NHS England launched the first ever Sexual Safety Charter in collaboration with healthcare systems, to provide staff with clear reporting mechanisms, training, and support. The charter currently has 329 signatories from across the health system, including ambulance trusts. Signatories commit to a zero-tolerance approach to any form of sexual misconduct in the workplace by implementing the charter’s ten actions and principles by July 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 08:00:22 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4799 label Biography information for Charlotte Nichols

1717851

	registered interest
	date	14/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when she plans to announce the pay award for NHS workers for 2024-25.
	tabling member constituency	Liverpool, Walton
	tabling member printed	Dan Carden
	uin	26212
	answer	answer is ministerial correction date of answer 17/05/2024 answer text <p>The Department has submitted its evidence to the NHS Pay Review Body, the Doctors and Dentists Pay Review Body, and the Senior Salaries Review Body, in order for them to make recommendations on a pay uplift for National Health Service workers for 2024/25. We will carefully consider the pay review bodies’ comments and recommendations when we receive them, and will respond in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/05/2024 07:43:30 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4651 label Biography information for Dan Carden

1717909

	registered interest
	date	14/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Joint Replacements: Waiting Lists
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people have been waiting for more than 12 months for (a) knee and (b) hip replacement surgery.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	26116
	answer	answer is ministerial correction date of answer 17/05/2024 answer text <p>Waiting list management information shows that there were 3,469 people waiting for more than 12 months for hip replacement surgery, and 5,714 people waiting for more than 12 months for knee replacement surgery, as of 5 May 2024.</p><p>The National Health Service has been hit by the most disruptive industrial action in its history, and as of April 2024, approximately 1.4 million hospital appointments have been rescheduled since December 2022. The NHS is working incredibly hard to ensure that those who have been waiting the longest receive treatment as soon as possible, and staff are going above and beyond to make this happen.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/05/2024 07:41:30 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3973 label Biography information for Grahame Morris

1717948

	registered interest
	date	14/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department has taken to improve awareness of sickle cell disease among healthcare professionals.
	tabling member constituency	Sheffield, Brightside and Hillsborough
	tabling member printed	Gill Furniss
	uin	26190
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The Government is committed to improving the lives of those living with rare diseases such as sickle cell disease, and published the UK Rare Diseases Framework in January 2021, providing the high-level approach for rare diseases. The framework outlines future priorities including increasing awareness of rare diseases among healthcare professionals. In England we publish action plans annually to address these priorities. As part of this plan we committed to developing an innovative digital educational resource, ‘GeNotes’, providing healthcare professionals with relevant and concise information to support patient management, linking to the NHS Genomic Test Directories, and signposting to extended learning opportunities. This resource includes information on sickle cell disease and is updated regularly.</p><p>There have been recent improvements to the haematology medical curriculum, with understanding sickle cell disease now described in the curriculum as a core competency. The National Healthcare Inequalities Improvement Programme has launched several products to support NHS England in raising awareness of sickle cell disease among healthcare professionals including NHS England’s Can you tell it's Sickle Cell campaign and e-learning module and a communications campaign to raise awareness of existing NHS England arrangements to support people with sickle cell disease to save money on the costs of regular prescriptions.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 14:17:22 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4571 label Biography information for Gill Furniss

1717955

	registered interest
	date	14/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will hold discussions with Royal Mail on the potential merits of treating NHS letters as first class post, in the context of possible reforms to the second class delivery service.
	tabling member constituency	Broxbourne
	tabling member printed	Sir Charles Walker
	uin	26093
	answer	answer is ministerial correction date of answer 17/05/2024 answer text <p>My Rt hon. Friend, the Secretary of State for Health and Social Care has written to Royal Mail regarding proposed reforms to the universal postal service, to ask what consideration has been given to patients and National Health Service impacts. A meeting with the Group Chief Executive of Royal Mail is currently being considered.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/05/2024 07:39:59 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1493 label Biography information for Sir Charles Walker

1718033

	registered interest
	date	14/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what her steps her Department is taking to improve early diagnosis rates for prostate cancer prior to the TRANSFORM trial findings.
	tabling member constituency	Ipswich
	tabling member printed	Tom Hunt
	uin	26279
	answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Improving early diagnosis of cancer, including prostate cancer, remains a priority for the Government and we are working towards the NHS Long Term Plan ambition of diagnosing 75% of stageable cancers at stage 1 and 2 by 2028. We know more people are surviving cancer in the United Kingdom than ever and that is partly down to early diagnosis.</p><p>Prior to the TRANSFORM trial, we are helping more people get diagnosed earlier by raising awareness, implementing the faster diagnosis standard and funding investment in research and diagnostics. NHS England takes steps to raise awareness of prostate cancer where there are opportunities to do so; for example NHS England partners with cancer alliances, charities and local representatives to reach people through projects in the heart of their communities. Cancer alliances have also been undertaking action to alert ‘at risk’ groups about prostate cancer, this is determined at a local level and so will vary depending on local needs and priorities.</p><p>To support faster diagnosis, NHS England is streamlining cancer pathways and in October 2022 introduced the best practice timed pathway for prostate cancer. This guidance recommends those with suspected prostate cancer undertake a multi-parametric magnetic resonance imaging (MRI) before biopsy, which ensures only those men most at risk of having cancer undergo an invasive biopsy.</p><p>In 2018, the Government announced £75 million of funding for clinical trials for prostate cancer, focusing on early diagnosis, survival rates and treatment options. Since April 2018, the National Institute for Health and Care Research (NIHR) has awarded over £60 million to more than 28 research studies relevant to prostate cancer. These include randomised controlled trials of different treatments, a randomised controlled trial of different methods of biopsy and a survivors’ rehabilitation evaluation.</p><p>Alongside cutting-edge research, we are helping more people get diagnosed earlier for cancer and other conditions by rolling out additional tests, checks and scans at 160 locations across England through our Community Diagnostics Centres programme.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 16:46:06 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4771 label Biography information for Tom Hunt

1718034

	registered interest
	date	14/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coeliac Disease: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which part of NHS England has accountability for coeliac disease diagnoses.
	tabling member constituency	Watford
	tabling member printed	Dean Russell
	uin	26290
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>Integrated care boards (ICB) commission services to meet the needs of their local populace. Diagnosis of coeliac disease falls within the portfolio of ICB-commissioned services. As such, NHS England does not have central accountability. However, NHS England has invested in senior clinical leadership in gastroenterology, which includes coeliac disease, as a priority workstream in the national Getting It Right First Time programme.</p><p>The diagnosis of coeliac disease commonly involves a blood test and, in some cases, a biopsy of the small intestine. Post-diagnosis, further blood tests, which check the levels of iron and other vitamins and minerals, may be required to assess how the condition has affected the individual, such as the potential for iron deficiency anaemia due to poor absorption of nutrients. A bone density scan may also be recommended if the condition is thought to affect the individual’s bones.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 14:05:34 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4812 label Biography information for Dean Russell

1718038

	registered interest
	date	14/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coeliac Disease: National Clinical Directors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of appointing a National Clinical Director within NHS England for coeliac disease.
	tabling member constituency	Southport
	tabling member printed	Damien Moore
	uin	26249
	answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>NHS England has invested in senior clinical leadership in gastroenterology, which includes coeliac disease, as a priority workstream in the national Getting It Right First Time programme.</p><p>To support healthcare professionals in the diagnosis and management of coeliac disease, and improve the diagnostic pathway nationally, the National Institute for Health and Care Excellence (NICE) has produced the guidance, Coeliac disease: recognition, assessment and management [NG20].</p><p>NICE guidelines represent best practice, and both healthcare professionals, including general practitioners, and service commissioners are expected to take them fully into account. Guidelines published by the NICE are not mandatory, and do not replace the judgement of clinicians in determining the most appropriate treatment for individual patients.</p><p>To assist with increasing the visibility of coeliac disease, the NICE promotes guidance via its website, newsletters, and other media. It also publishes information for the public, which explains the care people with coeliac disease should receive, as set out in the NICE guideline. Information for the public on coeliac disease is also published by the National Health Service and is available on the NHS website.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 14:17:27 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4669 label Biography information for Damien Moore